Hongryull Pyo

2.1k total citations
89 papers, 1.5k citations indexed

About

Hongryull Pyo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Hongryull Pyo has authored 89 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 21 papers in Radiation. Recurrent topics in Hongryull Pyo's work include Lung Cancer Diagnosis and Treatment (36 papers), Lung Cancer Treatments and Mutations (25 papers) and Advanced Radiotherapy Techniques (21 papers). Hongryull Pyo is often cited by papers focused on Lung Cancer Diagnosis and Treatment (36 papers), Lung Cancer Treatments and Mutations (25 papers) and Advanced Radiotherapy Techniques (21 papers). Hongryull Pyo collaborates with scholars based in South Korea, United States and Malaysia. Hongryull Pyo's co-authors include Jae Myoung Noh, Yong Chan Ahn, Hak Choy, George P. Amorino, Kim Js, Qianwen Cao, Dongryul Oh, Myung‐Ju Ahn, Youngmee Kim and Jin Seok Ahn and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Hongryull Pyo

87 papers receiving 1.5k citations

Peers

Countries citing papers authored by Hongryull Pyo

Since Specialization

Citations

This map shows the geographic impact of Hongryull Pyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongryull Pyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongryull Pyo more than expected).

Fields of papers citing papers by Hongryull Pyo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongryull Pyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongryull Pyo. The network helps show where Hongryull Pyo may publish in the future.

Co-authorship network of co-authors of Hongryull Pyo

This figure shows the co-authorship network connecting the top 25 collaborators of Hongryull Pyo. A scholar is included among the top collaborators of Hongryull Pyo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongryull Pyo. Hongryull Pyo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dose-Escalated Radiotherapy for Primary Tracheobronchial Adenoid Cystic Carcinoma 2024 ·Cancers ·(unknown), (unknown), Jae Myoung Noh, Kyungmi Yang, Hongryull Pyo	1
2	Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective Studies 2024 ·Cancer Research and Treatment ·(unknown), Sung Hee Lim, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Byong Chang Jeong, Se Hoon Park	2
3	Radiomics Analysis of 18F-FDG PET/CT for Prognosis Prediction in Patients with Stage III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiation Therapy Followed by Surgery 2023 ·Cancers ·Jang Yoo, (unknown), (unknown), Hojoong Kim, Yong Soo Choi, Hongryull Pyo, Myung‐Ju Ahn, Joon Young Choi	6
4	Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer 2023 ·Prostate International ·Tae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, Hyun Moo Lee, Seong Soo Jeon, Seong Il Seo, Byong Chang Jeong, Hwang Gyun Jeon, Hyun Hwan Sung, Minyong Kang, Wan Song, Jae Hoon Chung, (unknown), Won Park	3
5	Prospective Study of Proton Therapy for Lung Cancer Patients with Poor Lung Function or Pulmonary Fibrosis 2022 ·Cancers ·Jae Myoung Noh, Hongseok Yoo, (unknown), Hye Yun Park, Sun Hye Shin, Hongryull Pyo	3
6	Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer 2022 ·Life ·Kyungmi Yang, Yang‐Gun Suh, (unknown), Hongryull Pyo, Sung Ho Moon, Yong Chan Ahn, Dongryul Oh, (unknown), (unknown), Jae Myoung Noh	5
7	Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer 2022 ·Cancers ·(unknown), Kyungmi Yang, Jae Myoung Noh, Hongryull Pyo, Yong Chan Ahn	6
8	Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy 2020 ·Radiotherapy and Oncology ·Nalee Kim, Jae Myoung Noh, Woo‐Jin Lee, (unknown), (unknown), Ji Young Park, Hongryull Pyo	49
9	Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non–Small Cell Lung Cancer 2017 ·Journal of Thoracic Oncology ·Jong‐Mu Sun, (unknown), Dongryul Oh, Hong Kwan Kim, Se‐Hoon Lee, Yong Soo Choi, Hongryull Pyo, Jin Seok Ahn, Sin‐Ho Jung, Yong Chan Ahn, Young Tae Kim, Myung‐Ju Ahn, Jae Ill Zo, Young Mog Shim, Keunchil Park	26
10	Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience 2016 ·Cancer Research and Treatment ·Hyojung Park, Dongryul Oh, Yong Chan Ahn, Hongryull Pyo, (unknown), Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Hong Kwan Kim, Yong Soo Choi, Young Tae Kim, Jae Ill Zo, Young Mog Shim	4
11	Different Cell Cycle Modulation by Celecoxib at Different Concentrations 2012 ·Cancer Biotherapy and Radiopharmaceuticals ·Youngmee Kim, Hongryull Pyo	8
12	Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer 2012 ·Strahlentherapie und Onkologie ·Changhoon Song, Hongryull Pyo, (unknown), Young Kyung Lim, (unknown), H.J. Kim, (unknown), (unknown)	7
13	Cooperative Enhancement of Radiosensitivity After Combined Treatment of 17-(Allylamino)-17-Demethoxygeldanamycin and Celecoxib in Human Lung and Colon Cancer Cell Lines 2011 ·DNA and Cell Biology ·Youngmee Kim, Hongryull Pyo	12
14	Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated 2010 ·Molecular Cancer ·Soo‐Yeon Park, (unknown), Hongryull Pyo	34
15	Cyclooxygenase-2 (COX-2) Negatively Regulates Expression of Epidermal Growth Factor Receptor and Causes Resistance to Gefitinib in COX-2–Overexpressing Cancer Cells 2009 ·Molecular Cancer Research ·Youngmee Kim, Soo‐Yeon Park, Hongryull Pyo	19
16	Cyclooxygenase-2 Up-Regulates Ataxia Telangiectasia and Rad3 Related through Extracellular Signal-Regulated Kinase Activation 2009 ·Molecular Cancer Research ·Youngmee Kim, (unknown), Soo‐Yeon Park, Kwan Ho Cho, Joo Young Kim, Hongryull Pyo	10
17	Radiosensitivity Enhancement by Combined Treatment of Celecoxib and Gefitinib on Human Lung Cancer Cells 2006 ·Clinical Cancer Research ·Ji Sun Park, Hyun Jung Jun, (unknown), (unknown), Jin Soo Lee, Jae Ill Zo, Hongryull Pyo	29
18	Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Hongryull Pyo, Yong Bae Kim, Nam Hoon Cho, Chang‐Ok Suh, (unknown), (unknown), Gwi Eon Kim	12
19	Role of taxanes in the combined modality treatment of patients with locally advanced non-small cell lung cancer 2001 ·Expert Opinion on Pharmacotherapy ·Hak Choy, Hongryull Pyo, Kim Js, (unknown)	9
20	Topoisomerase I Inhibitors in the Combined Modality Therapy of Lung Cancer 2001 ·Clinical Lung Cancer ·Hak Choy, Kim Js, Hongryull Pyo, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact